Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of nitroglycerin plus first-line chemotherapy in advanced non-small cell lung cancer
2013-002050-78Phase 3Active
- Sponsor
- NVALT
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nitroglycerin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by NVALT. Primary endpoint: Progression-free survival. Started Jul 2013; status: active.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2013-002050-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002050-78.